These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2753987)

  • 1. [A new procedure for the determination of N-methylisoquinolinium ion, and its application].
    Ichinose T
    Nihon Ika Daigaku Zasshi; 1989 Jun; 56(3):218-23. PubMed ID: 2753987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the uptake of N-methylisoquinolinium ion into rat striatal slices using high-performance liquid chromatography with fluorimetric detection.
    Hirata Y; Minami M; Naoi M; Nagatsu T
    J Chromatogr; 1990 Mar; 503(1):189-95. PubMed ID: 2341514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of pyridinium salts, structurally related compounds of 1-methyl-4-phenylpyridinium ion (MPP+), on tyrosine hydroxylation in rat striatal tissue slices.
    Hirata Y; Sugimura H; Takei H; Nagatsu T
    Brain Res; 1986 Nov; 397(2):341-4. PubMed ID: 3099974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
    Javitch JA; D'Amato RJ; Strittmatter SM; Snyder SH
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2173-7. PubMed ID: 3872460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
    Kinemuchi H; Arai Y; Toyoshima Y
    Neurosci Lett; 1985 Jul; 58(2):195-200. PubMed ID: 3876524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP.
    Kindt MV; Youngster SK; Sonsalla PK; Duvoisin RC; Heikkila RE
    Eur J Pharmacol; 1988 Feb; 146(2-3):313-8. PubMed ID: 3131149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical investigations in vitro with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in preparations of rat brain.
    Markstein R; Lahaye D
    Eur J Pharmacol; 1984 Nov; 106(2):301-11. PubMed ID: 6335691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion.
    Hirata Y; Nagatsu T
    Neurosci Lett; 1985 Jun; 57(3):301-5. PubMed ID: 3929190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
    Shen RS; Abell CW; Gessner W; Brossi A
    FEBS Lett; 1985 Sep; 189(2):225-30. PubMed ID: 3876242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of tyrosine hydroxylation in tissue slices of the rat striatum by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Hirata Y; Nagatsu T
    Brain Res; 1985 Jun; 337(1):193-6. PubMed ID: 2860954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MPP+-induced increases in extracellular potassium ion activity in rat striatal slices suggest that consequences of MPP+ neurotoxicity are spread beyond dopaminergic terminals.
    Hollinden GE; Sanchez-Ramos JR; Sick TJ; Rosenthal M
    Brain Res; 1988 Dec; 475(2):283-90. PubMed ID: 3265070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors.
    Heikkila RE; Manzino L; Cabbat FS; Duvoisin RC
    Nature; 1984 Oct 4-10; 311(5985):467-9. PubMed ID: 6332989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
    Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential time courses of exogenous 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine and its metabolite MPP+ in the rat striatum and nucleus accumbens measured using in vivo voltammetry.
    Nakazato T; Akiyama A
    Brain Res; 1998 Nov; 812(1-2):150-6. PubMed ID: 9813295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-methylisoquinolinium ion as an inhibitor of tyrosine hydroxylase, aromatic l-amino acid decarboxylase and monoamine oxidase.
    Naoi M; Takahashi T; Parvez H; Kabeya R; Taguchi E; Yamaguchi K; Hirata Y; Minami M; Nagatsu T
    Neurochem Int; 1989; 15(3):315-20. PubMed ID: 20504500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
    Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
    Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine uptake inhibitory capacities of beta-carboline and 3,4-dihydro-beta-carboline analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation products.
    Drucker G; Raikoff K; Neafsey EJ; Collins MA
    Brain Res; 1990 Feb; 509(1):125-33. PubMed ID: 2137718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.